Testing effectiveness (Phase 2)Ended earlyNCT01313390
What this trial is testing
Everolimus and Docetaxel in Treating Patients With Recurrent, Locally Advanced, or Metastatic Head and Neck Cancer
Who this might be right for
Head and Neck Cancer
University College, London 4